Aetna Members: You may have received a letter stating that The Dermatology of Indiana is no longer in-network, this is NOT accurate information.
Please contact your insurance if you have any questions or concerns. We look forward to continuing to serve your dermatology needs.

2012

Psoriasis
Sponsor: Amgen
Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab
18 Years and Older
Phase: Phase 4
Start Date: February 2012
End Date: May 2015

Actinic Keratosis
Sponsor: LEO Pharma
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
18 Years and Older
Phase: Phase 3
Start Date: March 2012
End Date: July 2013

Psoriasis Vulgaris
Sponsor: LEO Pharma
LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris Age Info Here
Phase: Phase 2
Start Date: May 2012
End Date: November 2012

Psoriasis Vulgaris
Sponsor: LEO Pharma
LEO 90100 in the Treatment of Psoriasis Vulgaris
18 Years and Older
Phase: Phase 2
Start Date: May 2012
End Date: November 2012

Psoriasis
Sponsor: Eli Lilly and Company
A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)
18 Years and Older
Phase: Phase 3
Start Date: May 2012
End Date: July 2019

Actively Extending Plaque Psoriasis
Sponsor: Idera Pharmaceuticals, Inc.
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
18-70 Years
Phase: Phase 2
Start Date: May 2012
End Date: December 2012

Acne Vulgaris
Sponsor: Intrepid Therapeutics, Inc.
A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris
12 Years and Older
Phase: Phase 2
Start Date: June 2012
End Date: February 2014

Papulopustular Rosacea
Sponsor: Bayer
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
18 Years and Older
Phase: Phase 3
Start Date: September 2012
End Date: January 2014

Actinic Keratosis
Sponsor: Teva Pharmaceuticals USA
Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis
18 Years and Older
Phase: Phase 3
Start Date: September 2012
End Date: August 2013